The largest shareholder of Kakao Healthcare, a subsidiary of Kakao, will change to CHA CareS of CHA Bio Group. Kakao Healthcare is currently a 100% subsidiary of Kakao, but through Kakao's sale of ...
PANGYO, South Korea--(BUSINESS WIRE)--CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea. Investing over $250 million in the project, ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James ...
Cha Bio Group recently announced the acquisition of management rights for Kakao Healthcare, a subsidiary of Kakao Group. However, within the IT industry, there are discussions suggesting that while ...
CHA Bio Group will showcase its cell and gene therapy capabilities in the annual BIO International Convention 2024 (BIO USA), the world’s largest trade show in the biotechnology and pharmaceutical ...
EPS Surged to 1.27 HK Cents with a Three-year CAGR of 43.1%Robust Revenue Growth Driven by Strong Demand for Bogutai® and Omnichannel Strategy (28 August 2025 – Hong Kong) A fully integrated ...
Cha Bio Group, one of South Korea's largest biotechnology and healthcare companies, will acquire a minority stake in Kakao Healthcare as part of a share-swap agreement with its parent firm, Kakao Corp ...
SAN DIEGO, Oct. 5 /PRNewswire/ -- Stemedica International, S.A., ("Stemedica"), a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results